AI in Action E136: Jason Kim, Associate Director of Biomedical Informatics and Jenny Zhang, Director of Genomic Data Science at Immuneering
Welcome to episode 136 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.
Today’s guest is Jason Kim, Associate Director of Biomedical Informatics and Jenny Zhang, Director of Genomic Data Science at Immuneering. Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.
Utilizing its proprietary Disease Cancelling Technology, the company engineers medicines that reverse a disease signal across many relevant genes. Immuneering’s technologies have proven exceptionally rapid and capital-efficient in creating its pipeline. Concurrent with its internal programs, they provide unparalleled computational biology services to leading pharmaceutical and biotechnology companies.
In the show, Jenny and Jason will chat about:
Transitioning from academia into industry
How Immuneering are applying AI to improve drug discovery
What makes them stand out from the competition
Interesting projects they are working on
Why they love working at Immuneering
What they look for in the hiring process
What’s in store for the future
To find out more about Jenny & Jason and the great work at they do at Immuneering, check out the website www.immuneering.com or follow them on Twitter @immuneering. You can also connect with Jenny and Jason on Linkedin.
What did you make of Jenny and Jason’s podcast? Where do you see the future of AI within drug discovery and the healthcare sector heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.
If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.
Subscribe to the AI in Action Podcast:
Robert Elliott, VP, ServiceNow Services at Optimum Healthcare IT joins host Mark Kelly on the ServiceNow series of The Alldus Podcast to discuss understanding the key problems they solve for customers, stakeholder management, challenges to overcome & use cases of the impact they bring to customers
Oliver Stöckl, VP of EMEA at Brightfin joins host Mark Kelly on the ServiceNow series of The Alldus Podcast to discuss his work with Brightfin, examples of the benefits they bring to customers, defining the most important problems to solve and his advice to people looking at a career in ServiceNow
Richard Groff, Senior ServiceNow Program Manager at Latham & Watkins joins host Mark Kelly on the ServiceNow series of The Alldus Podcast to discuss the reality of implementing ServiceNow in your business, the importance of team building & talent development, managing your service models/CMDB & more